| Ashley Nixon-mongler, PHARMD | |
|
1814 Paris Rd, Columbia, MO 65201-5538 | |
| (573) 777-7373 | |
| (573) 777-7374 |
| Full Name | Ashley Nixon-mongler |
|---|---|
| Gender | Female |
| Speciality | Pharmacist |
| Location | 1814 Paris Rd, Columbia, Missouri |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1013358761 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 183500000X | Pharmacist | 2011019650 (Missouri) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Ashley Nixon-mongler, PHARMD 1814 Paris Rd, Columbia, MO 65201-5538 Ph: (573) 777-7373 | Ashley Nixon-mongler, PHARMD 1814 Paris Rd, Columbia, MO 65201-5538 Ph: (573) 777-7373 |
News Archive
Agensys, Inc., an affiliate of Tokyo-based Astellas Pharma Inc., and Seattle Genetics, Inc. today announced interim data from a phase I clinical trial evaluating ASG-5ME for the treatment of castration-resistant prostate cancer.
Over a 6-year period, patients with the genetic disease lipoprotein lipase deficiency (LPLD) who received a single gene therapy treatment of alipogene tiparvovec had a marked reduction in the severity and frequency of pancreatitis.
Oncotarget recently published "Targeted lymphodepletion with a CD45-directed antibody radioconjugate as a novel conditioning regimen prior to adoptive cell therapy" which reported that Chimeric antigen receptor T cell therapies, and adoptive cell therapy in general, represent one of the most promising anti-cancer strategies.
Ampio Pharmaceuticals, Inc., a company that discovers and develops new uses for previously approved drugs and new molecular entities, announced today that it reached agreement with the Therapeutic Goods Administration, Canberra, Australia, on a plan of drug manufacture and quality control for Zertane and the overall plan for the preparation of Common Technical Documents for the draft registration submission expected to be filed in June 2012.
Researchers recently developed novel diagnostic tools able to distinguish between the various strains of bacteria responsible for causing Lyme disease. For more than a decade, only one strain of B. burgdorferi had been sequenced, and although that helped research efforts, it was not sufficient to understand the relationship between geographic variations in strains and disease characteristics.
› Verified 6 days ago
Ms. Chunhan H Ma, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 800 Hospital Dr, Columbia, MO 65201 Phone: 573-814-6000 | |
Brooke Stiles, PHARM D Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 4710 Winding Wood Ct, Columbia, MO 65203 Phone: 573-355-6079 | |
Mrs. Debra Denise Tesoro, RPH, BCOP Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1705 E. Broadway, Suite 100, Columbia, MO 65201 Phone: 573-817-8527 Fax: 573-449-4246 | |
Dr. Carolin G Gatzke, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 222 E Broadway, Columbia, MO 65203 Phone: 573-874-3562 | |
Brittney Houston, PHARM D Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 800 Hospital Dr, Columbia, MO 65201 Phone: 573-814-6000 | |
Lee Ann Lawson, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 101 S Fairview Rd, Columbia, MO 65203 Phone: 573-884-1101 Fax: 573-884-1103 |